2026 Jonathan L. Bramson: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	61	3272	3016	82	72	213	10755

Overview

Jonathan L. Bramson is affiliated with McMaster University in Canada and has contributed extensively to medical research, with a focus on oncology, immunology, and molecular biology. Their body of work represents a significant engagement with the study of immune cell function, cancer therapies, and infectious diseases.

The main fields of study associated with Jonathan L. Bramson include Medicine, with subfields such as Oncology, Immunology, Molecular Biology, Infectious Diseases, and Pulmonary and Respiratory Medicine. The research spans several key topics, notably:

CAR-T cell therapy research
Immune Cell Function and Interaction
Immunotherapy and Immune Responses
SARS-CoV-2 and COVID-19 Research
T-cell and B-cell Immunology
Viral Infectious Diseases and Gene Expression in Insects
Virus-based gene therapy research

Jonathan L. Bramson has published in several frequent venues, prominently including:

bioRxiv (Cold Spring Harbor Laboratory)
Cytotherapy
Regular and Young Investigator Award Abstracts
Journal of Clinical Oncology
OncoImmunology

Their recent papers demonstrate a range of topics within immunotherapy and oncology. Notable publications include:

"The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma," 2020, Cell Stem Cell
"Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors," 2021, iScience
"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome," 2022, Molecular Metabolism
"De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors," 2020, Communications Biology
"The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy," 2023, Communications Biology

Frequent collaborators in Jonathan L. Bramson's research projects include Joanne A. Hammill, Jessica A. Breznik, Dawn M. E. Bowdish, Ishac Nazy, and Andrew P. Costa. These coauthors have contributed to multiple publications, reflecting sustained research partnerships.

Best Publications

Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models

Raluca Eftimie;Jonathan L. Bramson;David J. D. Earn

484
Citations
Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

J. L. Bramson;M. Hitt;C. L. Addison;W. J. Muller

295
Citations
TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

Anna Zganiacz;Michael Santosuosso;Jun Wang;Tony Yang

266
Citations
Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer

Chris P. Verschoor;Jennie Johnstone;Jamie Millar;Michael G. Dorrington

249
Citations
IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.

M J Greenberger;S L Kunkel;R M Strieter;N W Lukacs

236
Citations
A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity

Fiona Smaill;Mangalakumari Jeyanathan;Marek Smieja;Maria Fe Medina

230
Citations
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

Theodore Oliphant;Grant E. Nybakken;S. Kyle Austin;Qing Xu

224
Citations
Potentiating Cancer Immunotherapy Using an Oncolytic Virus

Byram W Bridle;Kyle B Stephenson;Jeanette E Boudreau;Sandeep Koshy

213
Citations
Maraba virus as a potent oncolytic vaccine vector.

Jonathan G Pol;Liang Zhang;Byram W Bridle;Kyle B Stephenson

206
Citations
Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

Yonghong Wan;Jonathan Bramson;Ronald Carter;Frank Graham

193
Citations
Defining the critical hurdles in cancer immunotherapy

Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

190
Citations
The use of adenoviral vectors for gene therapy and gene transfer in vivo

Jonathan L Bramson;Frank L Graham;Jack Gauldie

189
Citations
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen presenting cell properties

Moïra François;Moïra François;Raphaëlle Romieu-Mourez;Sophie Stock-Martineau;Marie Noëlle Boivin

175
Citations
Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL

Lea Luketic;Jordan Delanghe;Paul T. Sobol;Pingchang Yang

175
Citations
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.

Parvez Vora;Chitra Venugopal;Sabra Khalid Salim;Nazanin Tatari

174
Citations
IL-1α/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice

Fernando M. Botelho;Carla M. T. Bauer;Donna Finch;Jake K. Nikota

174
Citations
A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo

Edward M. Bertram;Wojciech Dawicki;Bradley Sedgmen;Jonathan L. Bramson

170
Citations
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.

J Bramson;K Dayball;C Evelegh;Y H Wan

164
Citations
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

J. Bramson;M. Hitt;W. S. Gallichan;K. L. Rosenthal

152
Citations
Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

JL Bramson;M Hitt;J Gauldie;FL Graham

146
Citations

Frequent Co-Authors

Yonghong Wan McMaster University

Mark Loeb McMaster University

Brian D. Lichty McMaster University

Zhou Xing McMaster University

Jack Gauldie McMaster University

Dawn M. E. Bowdish McMaster University

Frank L. Graham McMaster University

Ali A. Ashkar McMaster University

Jeffrey A. Medin Medical College of Wisconsin

Jason Moffat University of Toronto

External Links

Personal website of Jonathan L. Bramson

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can broaden career opportunities. Many students consider nursing programs designed for career changers, such as the best online bsn programs for non nurses. These programs provide foundational nursing knowledge, a valuable complement to Immunology expertise.

If you are looking for faster routes into nursing, absn programs with high acceptance rates offer accelerated timelines and more accessible admissions. These programs are ideal for students aiming to quickly enter the nursing workforce.

For entry-level healthcare roles, the fastest and easiest lpn programs can be a practical choice. Licensed Practical Nurses play a vital role in patient care coordination, and this credential can be earned with relative speed.

Those seeking advanced practice can explore options like the easiest nurse practitioner program. Becoming a Nurse Practitioner merges clinical expertise with patient management—skills complementary to an Immunology background and beneficial in specialized healthcare settings.